© 2001 American Heart Association, Inc.
Molecular Medicine |
Homeobox Protein Hex Induces SMemb/Nonmuscle Myosin Heavy Chain-B Gene Expression Through the cAMP-Responsive Element
From the Second Department of Internal Medicine (K.S., M.K., Y. Oyama, Y.A., T.T., H.S., Y.H., T.K., T.Y., Y.S., H.I., Y. Ohyama), Gunma University School of Medicine, Maebashi, and Department of Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Correspondence to Ryozo Nagai, MD, PhD, Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-9655, Japan. E-mail nagai-tky{at}umin.ac.jp
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Abstract—Recent studies have shown that the homeobox gene Hex plays an important role in inducing differentiation of vascular endothelial cells. In this study, we examined the expression of Hex in vascular smooth muscle cells (VSMCs) in vitro and in vivo. Immunohistochemistry showed a marked induction of Hex protein in neointimal VSMCs after balloon injury in rat aorta. Western and reverse transcriptase–polymerase chain reaction analyses demonstrated that Hex was abundantly expressed in cultured VSMCs, whereas it was undetectable in other cell types or in normal aorta. The expression pattern of Hex was similar to that of SMemb/NMHC-B, a nonmuscle isoform of myosin heavy chain that we have previously reported to be a molecular marker of dedifferentiated VSMCs. We next examined the role of Hex in SMemb gene transcription. Promoter analysis demonstrated that the sequence identical to consensus cAMP-responsive element (CRE) located at -481 of the SMemb promoter was critical for Hex responsiveness. Mutant Hex expression vector, which lacks the homeodomain, failed to stimulate SMemb gene transcription, suggesting the requirement of the homeodomain for its transactivation. Elecrophoretic mobility shift assay showed that Hex binds to a consensus binding sequence for homeobox proteins, but not to CRE. Cotransfection of protein kinase A expression vector increased the ability of Hex to stimulate SMemb promoter activity in a CRE-dependent manner. Overexpression of CRE binding protein (CREB), but not Mut-CREB which contains mutation at Ser133, strongly activated Hex-induced SMemb promoter activity. These results suggest that Hex mediates transcriptional induction of the SMemb/NMHC-B gene via its homeodomain, and Hex can function as a transcriptional modulator of CRE-dependent transcription in VSMCs.
Key Words: vascular smooth muscle cells • homeobox protein • gene expression
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Hex is a homeobox gene that is composed of a class of transcription factors that specify the body plan and regulate development of a wide variety of organisms.1 This transcription factor was originally isolated from hematopoietic tissues by polymerase chain reaction (PCR) using degenerate oligonucleotide primers corresponding to conserved homeodomain sequences.2 Expression of Hex transcripts is restricted to particular organs including hematopoietic tissue, lung, and liver.2 3 Whole-mount in situ hybridization demonstrated that Hex is transiently expressed in the nascent blood islands of the visceral yolk sac and later in embryonic angioblasts and endocardium4 5 and is generally downregulated during terminal cell differentiation.6 Furthermore, the overexpression of Hex using a retroviral vector resulted in the overgrowth of vascular endothelial cells.4 These results suggest that Hex plays a role in the development and growth of vascular endothelial cells. However, the expression of Hex in vascular smooth muscle cells (VSMCs) and its role in the transcription of VSMC genes remain unknown.
Proliferation and phenotypic modulation of VSMCs are a
hallmark of vascular
lesions.7 The concept of
phenotypic modulation is well illustrated at the molecular level by
changes in the regulation of the contractile proteins, such as smooth
muscle (SM) 
-actin,8 SM
myosin heavy chain
(MHC),9 10 11
myosin light chain,12
calponin,13 and
SM22.14 We and others
have shown that VSMCs express at least 4 MHC variants including 2
nonmuscle variants of
MHC.9 10 11 15
One non-muscle–specific isoform, NMHC-B/SMemb, is expressed during
embryonic development of the aorta, declines in the neonate and adult,
and is reinduced during atherogenesis. In contrast, SM1 and SM2, which
are expressed in differentiated VSMCs, decline during
atherogenesis.9 10 11
These changes in MHC expression suggest that an induced expression of
the SMemb gene is associated with the development of vascular disease.
In spite of extensive efforts, the molecular mechanisms underlying
regulated expression of the vascular disease-relevant genes remain to
be determined.
Here we demonstrate that Hex is expressed in cultured VSMCs in vitro, and we show that its expression is induced in neointimal smooth muscle cells (SMCs) in rat aorta after balloon injury in vivo, whereas its expression is undetectable in normal aorta or other cell types. We also show that the expression pattern of Hex is similar to that of SMemb, which we have previously reported to be a molecular marker for dedifferentiated VSMCs. Our results indicate that Hex activates the SMemb gene expression through a cAMP-responsive element (CRE) motif16 and suggest that the role of Hex in modulating the transcription of the genes whose expression is regulated by the protein kinase A (PKA) signaling pathway.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Cell Culture
SMCs and rat neonatal cardiac myocytes were prepared as described previously.17 18 C2/2 cells are an established cell line derived from rabbit aortic SMCs.17 NIH 3T3 fibroblasts, COS-7, and calf pulmonary artery endothelial (CPAE) cells were obtained from the American Type Cell Culture Collection. Cells were incubated in DMEM supplemented with 10% FBS and grown in a humidified incubator equilibrated with 5% CO2 at 37°C.
RNA Isolation and Reverse Transcriptase
(RT)–PCR
Total RNA isolation, RT-PCR, and Southern blotting
were performed as previously
described.18 Sequences of
primers for amplifying Hex and GAPDH cDNA are as follows: Hex sense,
5'-TTCCCGCGGACGGTGAACGAC-3'; Hex antisense,
5'-TCATCCAGCATTAAAGTAGCCTTT-3'; GAPDH sense,
5'-ACCACAGTCCATGCCATCAC-3'; and GAPDH antisense,
5'-TCCACCACCCTGTTGCTGTA-3'.
Anti-Hex Antibody
A short peptide specifying the carboxyl terminal end
of rabbit Hex
(N-ASQEDLESEISEDSDQEVDIEGDKGYFNAG-C)
was synthesized and used for immunization. The synthetic short peptide
was conjugated with BSA and injected subcutaneously into rabbits at
biweekly intervals. Titer of antisera was determined by
ELISA.
Immunohistochemistry and Western Blot
Analysis
All procedures were performed according to the
Guide for the Care and Use of Laboratory Animals (National
Institutes of Health). Immunohistochemistry of Hex was performed as
described previously.19
Thoracic aorta of adult male Wister rats were injured with a 2F balloon
embolectomy catheter as described
previously.20 Two weeks
after balloon injury, the animals were euthanized, and thoracic aortae
were subjected to immunohistochemistry. Immunostaining with anti-Hex
antibody was performed by using the Vectastain Elite ABC kit (Vector
Laboratories, Inc). Western blot analysis was performed as described
previously.19 In brief,
tissue or cell extracts were separated on 12% SDS-PAGE. The gels were
stained with Coomassie brilliant blue or the proteins were
electrophoretically transblotted onto a nitrocellulose membrane. The
membrane was immunologically stained with anti-Hex antibody or
anti–-actinin antibody (Sigma).
Plasmid Constructs
The promoter/luciferase fusion plasmids, SMemb-3.8k
and SM1/2–3.4k, have been
described.21 22
Serial deletion constructs, Del-950, Del-500, Del-481, Del-461, and
Del-185 were prepared by using the Deletion Kit (Takara). For
generation of Del-481µ, Del-481 was digested by
AatII, blunted by Klenow
enzyme, and then ligated by T4 ligase. Hex expression vector
(Hex/cytomegalovirus [CMV]) was constructed by PCR. The coding region
of murine Hex cDNA was amplified by PCR using upstream primers with a
HindIII site;
5'-CCCAAGCTTATGCAGTTCCCGCACCCGGGG-3',
and the reverse primer with an
XbaI site;
5'-CCCTCTAGATCATCCAGCATTAAAGTAGCC-3'.
The PCR product was subcloned into pRc/CMV (Invitrogen). For generation
of mutant Hex expression plasmid that lack its homeodomain
(
Hex/CMV), PCR products of Hex (1–400) and Hex (586–816) were
ligated and inserted into pRc/CMV. 10xCRE-TK/luciferase vector was
prepared as follows: 2 complementary oligonucleotides containing CRE
were annealed and 10 copies of the annealed oligonucleotides were
inserted into TK/pGL3, which contains the thymidine kinase (TK)
promoter upstream of the luciferase gene, as follows: CRE top,
5'-TCGAGGATTGCCTGACGTCAGAGAGCC-3',
and CRE-bottom, 5'-TCGAGGCTCTCTGACGTCAG-GCAATCC-3'.
The sequence responsible for CRE is underlined. CRE binding protein
(CREB), Mut-CREB, and PKA expression vector and TK/pGL3 plasmid were
generous gifts from Drs Mark Montminy (Salk Institute for Biological
Studies) and Jean-Michel Gauthier (Laboratoire GlaxoWellcome),
respectively.
Transfection and Luciferase Assay
All of the transfection and luciferase assays were
performed using CPAE cells. Cationic liposome-mediated transfection and
luciferase assays were performed according to the manufacturer’s
specifications (Promega). Data are mean±SEM of at least 3 independent
experiments in duplicate.
Preparation of Nuclear Extracts and
Electrophoretic Mobility Shift Assays (EMSAs)
Preparation of nuclear extracts and EMSA were
done as previously
described.19 The sequences
of the oligonucleotides used as a probe were as follows, with CRE motif
underlined and mutations of the wild type in bold face: SMemb-481,
5'-GGGGGGTGACGTCAGGCCTCT-3';
CRE mut,
5'-GGGGGGTGCAACCAGGCCTCT-3'; HS
for homeobox protein binding sequence,
5'-TGCCACTTAATCATT-AAGGGAGCC-3';
and HS mut,
5'-TGCCACTGCCTCAGCCA-GGGAGCC-3'.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Hex Is Expressed in Cultured VSMCs
RT-PCR analysis demonstrated that Hex mRNA is ubiquitously expressed in vivo, although little was present in aorta (Figure 1A
). In cultured cells, both primary cultures of rat
aortic VSMCs and C2/2 cells, an established VSMC line derived from
rabbit aorta, express Hex mRNA. Because most VSMCs in normal aorta show
the contractile phenotype and primary cultured VSMCs exhibit the
synthetic phenotype,23 these
data suggest that expression of Hex is dependent on the differentiation
state of VSMCs.
|
Western blot analysis of the various tissues showed that the
measurable amount of Hex protein is detected only in liver. As shown in
Figure 1B
, cultured VSMCs but not CPAE cells (endothelial
cells), NIH 3T3 cells (fibroblasts), or cardiac myocytes expressed Hex
protein as indicated by the single band with an approximate molecular
mass of 35 kDa. These results indicate that expression of Hex
protein in cultured VSMCs is cell type specific.
Hex Is Induced in Neointima After Balloon
Injury
We next examined whether Hex is expressed in neointimal
VSMCs in response to injury. As shown in
Figure 2A, immunohistochemistry of the cross section of rat
aorta showed that Hex was significantly induced in neointima 1 week
after balloon injury, whereas the medial layer showed little
expression. Immunoreactivity to anti-Hex antibody appears to be
specific because preimmune serum showed no reactivity. Expression of
Hex reached its peak at 2 weeks after balloon injury and declined
thereafter. Western blot analysis of the protein extracts from aorta
showed that Hex was strongly induced in balloon-injured aorta as
compared with normal aorta
(Figure 2B). As shown in
Figure 2C, comparison of the time course of the Hex
expression with that of the SMemb expression revealed that both
proteins were induced in a similar fashion in response to vascular
injury. Taken together with the data indicating Hex expression in VSMCs
(Figure 1B), these results suggest that expression of Hex is
induced in neointimal SMCs.
|
Hex Transactivates the SMemb Gene
To examine the transcriptional effects of Hex on the
SMemb promoter, CPAE cells were cotransfected with the SMemb
promoter-luciferase construct SMemb-3.8k that contains 3.8 kb of the
promoter region along with the Hex expression vector (Hex/CMV). CPAE
cells were utilized for reporter assays for the lack of endogenous Hex
expression (see
Figure 1B). As shown in
Figure 3A, cotransfection of Hex/CMV significantly induced
the luciferase activity of the SMemb promoter. The effect of Hex/CMV is
apparently promoter specific, because the SM1/2 promoter-luciferase
construct SM1/2-3.4k was not responsive to Hex.
|
Homeodomain Is Required for Hex-Induced
Transactivation
To assess whether the homeodomain in Hex affects SMemb
gene transcription, the mutant Hex expression vector (Hex/CMV),
which lacks its homeodomain, was transfected into CPAE cells. First we
tested whether both Hex and Hex are localized to the nuclei after
transfection. Anti-Hex antibody clearly detected the expression of
either Hex or Hex
(Figure 3B). We then examined the effects of Hex and Hex
on the promoter activity of SMemb-3.8k. As shown in
Figure 3C, Hex/CMV transactivated the SMemb promoter
activity 
7-fold higher as compared with control vector, but
Hex/CMV showed no effect on this promoter. These data suggest that
the homeodomain is critical for the transactivation of
Hex.
Hex Activates the SMemb Gene Expression Through
CRE
To define the Hex response element within the SMemb
promoter, a series of SMemb promoter deletion constructs was
cotransfected with Hex/CMV in CPAE cells. The SMemb-luciferase
constructs Del-950 and Del-481 as well as SMemb-3.8k were similarly
activated by Hex. However, further deletion to -461 almost completely
eliminated Hex responsiveness. Likewise, Del-185 and promoterless pGL3
constructs did not respond to Hex
(Figure 4A). These results suggest that the 5'-end of the
Hex-response sequence is localized to the sequence between -481 and
-461. Sequence analysis of this region revealed an sequence identical
to CRE, 5'-TGACGTCA-3', at -481. To test whether CRE is required for
the activation by Hex, the mutant constructs SMemb-3.8kµ and
Del-481µ
(Figure 4B) with disrupted CRE motifs in SMemb-3.8k and
Del-481, respectively, were cotransfected with Hex/CMV. As shown in
Figure 4C, mutation of CRE clearly abolished the increase in
promoter activity of SMemb-3.8k and Del-481 by Hex. These data
suggest that CRE at -481 is critical for activation of the SMemb
promoter by Hex.
|
Hex Stimulates CRE-Dependent Gene
Transcription
To test whether the CRE motif at -481 is functional,
a PKA expression vector was cotransfected with the SMemb promoter. As
shown in
Figure 5A, PKA overexpression increased the promoter
activity of SMemb-3.8k (2.5-fold). Cotransfection of Hex expression
vector alone increased the SMemb promoter activity by 3-fold. We next
examined the synergistic effects of PKA on Hex-induced SMemb promoter
activity. Cotransfection of PKA expression vector significantly
enhanced Hex-induced SMemb promoter activity (14-fold). To verify
whether the transactivation of Hex is CRE dependent, we used 10xCRE-TK
promoter, in which 10 copies of short fragments containing the
consensus CRE motif were inserted into the TK-luciferase reporter
vector. As shown in
Figure 5B, the 10xCRE-TK promoter was activated by Hex
expression vector by 2.5-fold. PKA overexpression further augmented
this activation. These data strongly suggest that the transactivating
function of Hex is CRE dependent, and it is further potentiated by the
PKA signaling pathway.
|
CREB Potentiates Hex-Induced SMemb Promoter
Activity
Because CREB constitutes the major component of the
PKA-mediated gene transcription and Hex activates the SMemb gene
expression through CRE, we tested whether CREB plays a role in
Hex-induced SMemb gene transcription. As shown in
Figure 5C, CREB by itself activated SMemb promoter activity
by 4-fold, and more importantly, cotransfection of CREB with Hex
expression vector strongly enhanced the activation of SMemb promoter by
Hex (70-fold). Specificity of this effect was determined by using
the construct Mut-CREB in which residue Ser133 is mutated. Mut-CREB has
been reported not to activate the CRE-dependent transcription because
Ser133 is essential for CREB
function.24 Mut-CREB had no
effects on SMemb promoter activity, and cotransfection with Hex only
minimally increased Hex-mediated SMemb promoter activity. These results
suggest that Hex and CREB synergistically activate SMemb gene and
further support our finding that PKA signaling increases Hex-mediated
SMemb expression.
CREB but Not Hex Binds to CRE
To pursue the molecular mechanism underlying the
activation of the CRE-dependent transcription by Hex, we examined
whether Hex is capable of binding directly to the CRE motif. The
labeled oligonucleotide probe containing the consensus CRE motif, which
we designated as SMemb-481, was incubated with nuclear extracts from
VSMCs. As shown in
Figure 6A, a DNA:protein complex was formed with this probe
in a sequence-specific manner; 100-fold molar excess of unlabeled
probe, but not its mutated sequence, completely abolished the complex
formation. Supershift experiments indicated that this shifted complex
contains CREB but not Hex, because incubation of the nuclear extracts
with anti-CREB antibody clearly shifted the complex, whereas anti-Hex
antibody had no effect on the complex. The presence of Hex in the
nuclear extracts was confirmed by incubating the nuclear extracts with
the probe containing the consensus binding sequence for Hex,
5'-ATTAA-3'.2 A labeled probe
containing this motif, designated as HS (homeobox protein binding
sequence), formed a complex with nuclear extracts from cultured VSMCs.
As shown in
Figure 6B, the single band corresponding to the DNA:protein
complex was abolished by 100-fold molar excess of unlabeled HS probe
but not by a mutated HS probe. Furthermore, a supershifted band was
detected by addition of anti-Hex antibody to the reaction, indicating
that Hex, which is expressed in cultured VSMCs, has the ability to bind
to DNA under our experimental conditions. Consistent with the results
of Western blot analysis
(Figure 1B), our EMSA data showed that the shifted complex
was detected in the nuclear extracts from primary cultures of VSMCs and
C2/2 cells, but not from CPAE cells, NIH 3T3 fibroblast cells, or
cardiac myocytes
(Figure 6B). These results suggest that Hex is specifically
expressed in VSMCs.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In the present study, we demonstrate that Hex mRNA is expressed in cultured VSMCs but not in other cell types in vitro and that its protein is induced in neointimal SMCs after balloon injury. In addition, we show that Hex specifically activates transcription driven by the SMemb promoter, which is known to be a molecular marker for dedifferentiated VSMCs, and the cis element required for the transactivation is identical to CRE. Furthermore, activation of the SMemb gene by Hex is potentiated by overexpression of PKA or CREB. From these results, we conclude that Hex activates SMemb gene transcription through a novel mechanism by which Hex activates the PKA-dependent transcriptional machinery in VSMCs.
Three lines of evidence support the hypothesis that Hex plays a role in dedifferentiation of VSMCs. Previous studies have suggested the role of Hex in cellular differentiation in vascular endothelial cells4 5 23 and leukemic cells.6 First, we observed that Hex expression vector transactivates the SMemb promoter but not the SM1/2 promoter. Because dedifferentiated VSMCs predominantly express the SMemb rather than the SM1/2 gene,9 10 11 these results favor the notion that Hex promotes dedifferentiation of VSMCs. Second, we showed that Hex protein and its transcripts are preferentially expressed in VSMCs of synthetic phenotype rather than in normal aorta. As shown in the immunohistochemistry of balloon-injured aorta, Hex was strongly induced in neointima in which most SMCs are of synthetic phenotype.9 10 11 Lastly, we showed that Hex and SMemb expression are colocalized within the neointima. These findings suggest that Hex may play a role in regulating gene expression in dedifferentiated VSMCs.
The role of Hex in the dedifferentiation of VSMCs is unexpected but not surprising, because previous studies have shown that Hex expression is lost on differentiation into mature monocytes, macrophages, and megakaryocytes6 and is downregulated once endothelial cell differentiation commences in the developing Xenopus4 and mouse.5 Furthermore, other homeobox genes have also been reported to be involved in the process of cellular dedifferentiation or proliferation. For example, Hox 11, the homeobox gene most related to Hex, disrupts a G2/M cell-cycle checkpoint.25 Another homeobox gene, Evx-1, transactivates the tenascin gene,26 the expression of which is developmentally regulated and is induced after balloon injury to the vessel wall.27 These reports support our assumption that Hex may play a role in the establishment of the synthetic phenotype as well as in the maintenance of this phenotype via transcriptional activation of dedifferentiated VSMC genes.
One of the major findings in the present study is that Hex
activates SMemb gene transcription via CRE but not AT-rich sequences to
which Hex is known to bind.2
Cotransfection of various SMemb promoter/luciferase constructs with Hex
expression vector demonstrated that a CRE at -481 of the SMemb
promoter was critical for the activation by Hex, and mutation of the
CRE motif completely abolished Hex-induced increase in reporter
activity. Hex also stimulated a 10xCRE-TK promoter but not TK promoter
alone, confirming that the transactivating function of Hex is CRE
dependent. These findings are not consistent with the previous reports
indicating that most homeobox proteins are known to regulate gene
transcription through AT-rich
sequences.1 However, there
are some precedent reports in which homeobox proteins transactivate
gene expression through a sequence distinct from AT-rich sequences. For
example, Drosophila
eve homeobox protein binds to
both AT-rich and GC-rich sites with a similar
affinity,28 whereas
zen protein is capable of
binding to only GC-rich
sites.29 A report on Pbx may
be relevant to this study because Pbx regulates the CYP17 promoter,
which encodes 17-hydroxylase/17,20-lyase cytochrome P-450, through
direct binding to CRE.30
Thus, it is becoming clear that the transactivation by homeobox
proteins is not solely dependent on the authentic AT-rich sequence,
which is considered to be a core of the homeobox binding
sequence.
Our data in this study raised the possibility that Hex induces gene expression by interacting with CREB. The results from EMSA showed that Hex did not bind directly to CRE, whereas CREB constitutes a DNA-protein complex formed with CRE as expected. Reporter analysis of the SMemb promoter revealed that cotransfection of both Hex and CREB expression vectors synergistically stimulate CRE-dependent gene transcription. Interaction between homeobox proteins and CREB has been recently described. Lorentz et al31 reported that intestinal homeobox protein, Cdx2, interacts with CREB and increases the ability of Cdx2 to transactivate target genes through AT-rich sequences. Therefore, Hex might interact with DNA binding protein to CRE, such as CREB, and stimulate gene transcription. Results of our cotransfection assays using mutant Hex expression vector suggest that the interaction between Hex and CREB takes place through the homeodomain. We attempted to determine the physical interaction between Hex and CREB by using the following 2 different approaches: 2-hybrid luciferase assay and immunoprecipitation experiments. However, we did not obtain the data suggesting the physical interaction between Hex and CREB by both approaches. Although we cannot entirely exclude such a possibility, these results rather suggest that synergistic activation of the SMemb promoter by Hex and CREB may not be due to the direct interaction between these 2 factors. The precise molecular mechanism, including participation of the coactivators such as CBP/p300, will deserve further study.
Our findings that PKA and CREB activate Hex-mediated transcription of the SMemb gene suggest the role of cAMP-PKA-CREB pathway in cellular proliferation because SMemb expression is associated with cytokinesis of VSMCs. Although a number of studies have demonstrated that the cAMP-PKA pathway inhibits cellular proliferation, accumulating evidence indicates that cAMP also mediates mitogenesis of the cells, including VSMCs. Owen32 reported that prostaglandin E1 via cAMP induces DNA synthesis in the quiescent A10 rat embryo VSMC line. In addition, CREB, an effector of the cAMP-dependent pathway, forms heterodimers with c-Fos to transactivate the cyclin A promoter through CRE in cultured VSMCs.33 These observations support our assumption that effects of the cAMP-PKA signaling pathway on stimulating dedifferentiation may be partly mediated through the activation of the genes lying downstream of Hex.
In summary, we demonstrate that the homeobox protein Hex, which is induced in neointimal SMCs after balloon injury, activates the SMemb gene transcription through its homeodomain. Furthermore, our data indicate that Hex activates transcription in a CRE-dependent manner in corroboration with the PKA or CREB expression vectors. Taken together, these data suggest that Hex may play a role in the phenotypic modulation of VSMCs, and interaction between PKA- or CREB-dependent transcriptional machinery and homeobox proteins may provide novel insight into the molecular mechanisms underlying the development of vascular disease in which proliferation and phenotypic change of VSMCs play a major role.
|
Acknowledgments |
|---|
This study was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan and a grant from the Japanese Cardiovascular Foundation (to M.K. and R.N.).
|
Footnotes |
|---|
Original received June 1, 2000; resubmission received October 9, 2000; revised resubmission received November 6, 2000; accepted November 6, 2000.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Wright CV, Cho KW, Oliver G, De RE. Vertebrate homeodomain proteins: families of region-specific transcription factors. Trends Biochem Sci. 1989;14:52–56.[Medline] [Order article via Infotrieve]
2.
Crompton MR,
Bartlett TJ, MacGregor AD, Manfioletti G, Buratti E, Giancotti V,
Goldwin GH. Identification of a novel vertebrate homeobox gene
expressed in haematopoietic cells. Nucleic
Acids Res. 1992;20:5661–5667.
3. Hromas R, Radich J, Collins S. PCR cloning of an orphan homeobox gene (PRH) preferentially expressed in myeloid and liver cells. Biochem Biophys Res Commun. 1993;195:976–983.[Medline] [Order article via Infotrieve]
4. Newman CS, Chia F, Krieg PA. The XHex homeobox gene is expressed during development of the vascular endothelium: overexpression leads to an increase in vascular endothelial cell number. Mech Dev. 1997;66:83–93.[Medline] [Order article via Infotrieve]
5. Thomas PQ, Brown A, Beddington RS. Hex: a homeobox gene revealing peri-implantation asymmetry in the mouse embryo and an early transient marker of endothelial cell precursors. Development. 1998;125:85–94.[Abstract]
6.
Manfioletti G,
Gattei V, Buratti E, Rustighi A, De Iuliis A, Aldinucci D, Goodwin GH,
Pinto A. Differential expression of a novel proline-rich homeobox gene
(Prh) in human hematolymphopoietic cells.
Blood. 1995;85:1237–1245.
7.
Owens GK.
Regulation of differentiation of vascular smooth muscle cells.
Physiol Rev. 1995;75:487–517.
8. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest. 1984;73:148–152.
9.
Kuro-o M, Nagai R,
Tsuchimochi H, Katoh H, Yazaki Y, Ohkibo A, Takaku F. Developmentally
regulated expression of vascular smooth muscle myosin heavy chain
isoforms. J Biol Chem. 1989;264:18272–18275.
10.
Kuro-o M, Nagai
R, Nakahara K, Nakahara K, Katoh H, Tsai R, Tsuchimochi H, Yazaki Y,
Ohkubo A, Takaku F. cDNA cloning of a myosin heavy chain isoform in
embryonic smooth muscle and its expression during vascular development
and in arteriosclerosis. J Biol
Chem. 1991;266:3768–3773.
11.
Nagai R, Kuro-o
M, Babij P, Periasamy M. Identification of two types of smooth muscle
myosin heavy chain isoforms by cDNA cloning and immunoblot analysis.
J Biol Chem. 1989;264:9734–9737.
12.
Nabeshima Y,
Nabeshima Y, Nonomura Y, Fujii KY. Nonmuscle and smooth muscle myosin
light chain mRNAs are generated from a single gene by the
tissue-specific alternative RNA splicing.
J Biol Chem. 1987;262:10608–10612.
13. Gimona M, Sparrow MP, Strasser P, Herzog M, Small JV. Calponin and SM 22 isoforms in avian and mammalian smooth muscle: absence of phosphorylation in vivo. Eur J Biochem. 1992;205:1067–1075.[Medline] [Order article via Infotrieve]
14.
Li L, Miano JM,
Cserjesi P, Olson EN. SM22 , a marker of adult smooth muscle, is
expressed in multiple myogenic lineages during embryogenesis.
Circ Res. 1996;78:188–195.
15.
Kawamoto S,
Adelstein RS. Chicken nonmuscle myosin heavy chains: differential
expression of two mRNAs and evidence for two different polypeptides.
J Cell Biol. 1991;112:915–924.
16.
Deutsch PJ,
Hoeffler JP, Jameson JL, Lin JC, Habener JF. Structural determinants
for transcriptional activation by cAMP-responsive DNA elements.
J Biol Chem. 1988;263:18466–18472.
17.
Sasaki Y, Uchida
T, Sasaki Y. A variant derived from rabbit aortic smooth muscle:
phenotype modulation and restoration of smooth muscle characteristics
in cells in culture. J Biochem
Tokyo. 1989;106:1009–1018.
18.
Sekiguchi K,
Yokoyama T, Kurabayashi M, Okajima F, Nagai R.
Sphingosylphosphorylcholine induces a hypertrophic growth response
through the mitogen-activated protein kinase signaling cascade in rat
neonatal cardiac myocytes. Circ
Res. 1999;85:1000–1008.
19.
Watanabe N,
Kurabayashi M, Shimomura Y, Kawai-Kowase K, Hoshino Y, Manabe I,
Watanabe M, Aikawa M, Kuro-o M, Suzuki T, Yazaki Y, Nagai R. BTEB2, a
Kruppel-like transcription factor, regulates expression of the
SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene.
Circ Res. 1999;85:182–191.
20.
Kowase K,
Kurabayashi M, Hoshino Y, Ohyama Y, Nagai R. Transcriptional activation
of the zinc finger transcription factor BTEB2 gene by Egr-1 through
mitogen-activated protein kinase pathways in vascular smooth muscle
cells. Circ Res. 1999;85:787–795.
21. Manabe I, Kurabayashi M, Shimomura Y, Kuro-o M, Watanabe N, Watanabe M, Aikawa M, Suzuki T, Yazaki Y, Nagai R. Isolation of the embryonic form of smooth muscle myosin heavy chain (SMemb/NMHC-B) gene and characterization of its 5'-flanking region. Biochem Biophys Res Commun. 1997;239:598–605.[Medline] [Order article via Infotrieve]
22.
Watanabe M,
Sakomura Y, Kurabayashi M, Manabe I, Aikawa M, Kuro-o M, Suzuki T,
Yazaki Y, Nagai R. Structure and characterization of the 5'-flanking
region of the mouse smooth muscle myosin heavy chain (SM1/2) gene.
Circ Res. 1996;78:978–989.
23.
Chamley CJ,
Campbell GR, Ross R. The smooth muscle cell in culture.
Physiol Rev. 1979;59:1–61.
24. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 1989;59:675–680.[Medline] [Order article via Infotrieve]
25. Kawabe T, Muslin AJ, Korsmeyer SJ. HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. Nature. 1997;385:454–458.[Medline] [Order article via Infotrieve]
26. Hedin U, Holm J, Hansson GK. Induction of tenascin in rat arterial injury: relationship to altered smooth muscle cell phenotype. Am J Pathol. 1991;139:649–656.[Abstract]
27.
Jones FS,
Chalepakis G, Gruss P, Edelman GM. Activation of the cytotactin
promoter by the homeobox-containing gene Evx-1.
Proc Natl Acad Sci
U S A. 1992;89:2091–2095.
28.
Hoey T, Warrior
R, Manak J, Levine M. DNA-binding activities of the
Drosophila melanogaster
even-skipped protein are mediated by its homeo domain and influenced by
protein context. Mol Cell Biol. 1988;8:4598–4607.
29.
Yamaguchi M,
Hirose F, Nishida Y, Matsukage A. Repression of the
Drosophila proliferating-cell
nuclear antigen gene promoter by zerknullt protein.
Mol Cell Biol. 1991;11:4909–4917.
30. Ogo A, Waterman MR, McAllister JM, Kagawa N. The homeodomain protein Pbx1 is involved in cAMP-dependent transcription of human CYP17. Arch Biochem Biophys. 1997;348:226–231.[Medline] [Order article via Infotrieve]
31.
Lorentz O, Suh
ER, Taylor JK, Boudreau F, Traber PG. cAMP response element-binding
protein interacts with the homeodomain protein Cdx2 and enhances
transcriptional activity. J Biol
Chem. 1999;274:7196–7199.
32.
Owen NE. Effect
of prostaglandin E1 on DNA synthesis in vascular smooth muscle cells.
Am J Physiol. 1986;250:C584–C588.
33. Sylvester AM, Chen D, Krasinski K, Andres V. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest. 1998;101:940–948.>[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  D.-W. Lin, I.-C. Chang, A. Tseng, M.-L. Wu, C.-H. Chen, C. A. Patenaude, M. D. Layne, and S.-F. Yet Transforming Growth Factor {beta} Up-regulates Cysteine-rich Protein 2 in Vascular Smooth Muscle Cells via Activating Transcription Factor 2 J. Biol. Chem., May 30, 2008; 283(22): 15003 - 15014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ichiki Role of cAMP Response Element Binding Protein in Cardiovascular Remodeling: Good, Bad, or Both? Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Barlow, P. Rose, R. A. Pulver-Kaste, and K. M. Lounsbury Excitation-transcription coupling in smooth muscle J. Physiol., January 1, 2006; 570(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Najwer and B. Lilly Ca2+/calmodulin-dependent protein kinase IV activates cysteine-rich protein 1 through adjacent CRE and CArG elements Am J Physiol Cell Physiol, October 1, 2005; 289(4): C785 - C793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Crespo, J. Martinez-Gonzalez, J. Rius, and L. Badimon Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation Cardiovasc Res, August 1, 2005; 67(2): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Foley and M. Mercola Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex Genes & Dev., February 1, 2005; 19(3): 387 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hallaq, E. Pinter, J. Enciso, J. McGrath, C. Zeiss, M. Brueckner, J. Madri, H. C. Jacobs, C. M. Wilson, H. Vasavada, et al. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels Development, October 15, 2004; 131(20): 5197 - 5209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Oyama, K. Kawai-Kowase, K. Sekiguchi, M. Sato, H. Sato, M. Yamazaki, Y. Ohyama, Y. Aihara, T. Iso, E. Okamaoto, et al. Homeobox Protein Hex Facilitates Serum Responsive Factor-Mediated Activation of the SM22{alpha} Gene Transcription in Embryonic Fibroblasts Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1602 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Owens, M. S. Kumar, and B. R. Wamhoff Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease Physiol Rev, July 1, 2004; 84(3): 767 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Minami, T. Murakami, K. Horiuchi, M. Miura, T. Noguchi, J.-i. Miyazaki, T. Hamakubo, W. C. Aird, and T. Kodama Interaction between Hex and GATA Transcription Factors in Vascular Endothelial Cells Inhibits flk-1/KDR-mediated Vascular Endothelial Growth Factor Signaling J. Biol. Chem., May 14, 2004; 279(20): 20626 - 20635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Akiyama, T. Tanaka, H. Itakura, H. Kanai, T. Maeno, H. Doi, M. Yamazaki, K. Takahashi, Y. Kimura, S. Kishi, et al. Inhibition of Ocular Angiogenesis by an Adenovirus Carrying the Human von Hippel-Lindau Tumor-Suppressor Gene In Vivo Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1289 - 1296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kasamatsu, A. Sato, T. Yamamoto, V. W. Keng, H. Yoshida, Y. Yamazaki, M. Shimoda, J.-i. Miyazaki, and T. Noguchi Identification of the Transactivating Region of the Homeodomain Protein, Hex J. Biochem., February 1, 2004; 135(2): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tokunou, R. Shibata, H. Kai, T. Ichiki, T. Morisaki, K. Fukuyama, H. Ono, N. Iino, S. Masuda, H. Shimokawa, et al. Apoptosis Induced by Inhibition of Cyclic AMP Response Element-Binding Protein in Vascular Smooth Muscle Cells Circulation, September 9, 2003; 108(10): 1246 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Kumar and G. K. Owens Combinatorial Control of Smooth Muscle-Specific Gene Expression Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 737 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Buxton, E. Golomb, and R. S. Adelstein Induction of Nonmuscle Myosin Heavy Chain II-C by Butyrate in RAW 264.7 Mouse Macrophages J. Biol. Chem., April 18, 2003; 278(17): 15449 - 15455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Puppin, A. V. D'Elia, L. Pellizzari, D. Russo, F. Arturi, I. Presta, S. Filetti, C. W. Bogue, L. A. Denson, and G. Damante Thyroid-specific transcription factors control Hex promoter activity Nucleic Acids Res., April 1, 2003; 31(7): 1845 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakagawa, M. Abe, T. Yamazaki, H. Miyashita, H. Niwa, S. Kokubun, and Y. Sato HEX Acts as a Negative Regulator of Angiogenesis by Modulating the Expression of Angiogenesis-Related Gene in Endothelial Cells In Vitro Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Gorski and K. Walsh Control of Vascular Cell Differentiation by Homeiobox Transcription Factors Circ. Res., January 19, 2001; 88(1): 7 - 8. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||